cbdMD (YCBD) Total Debt (2016 - 2024)

cbdMD (YCBD) posted Total Debt of $362021.0 for Q4 2024, down 83.58% sequentially from $2.2 million in Q3 2024.

cbdMD (YCBD) Total Debt (2016 - 2024) Analysis & Trends

cbdMD has reported Total Debt for 9 years, with the latest figure at $362021.0 in Q4 2024.

Quarterly Total Debt changed N/A year-over-year to $362021.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $362021.0 (changed N/A YoY) and the FY2024 annual result came in at $2.2 million, up 24491200.0% from the prior year.
Total Debt fell to $362021.0 in Q4 2024 per YCBD's latest filing, from $2.2 million in the prior quarter.
Over five years, Total Debt peaked at $2.2 million in Q3 2024 and troughed at $9.0 in Q3 2023.
A 5-year average of $586652.8 and a median of $182714.0 in 2020 frame the typical range for Total Debt.
The sharpest annual moves came in 2023 and 2024: Total Debt tumbled 99.99% in 2023, then soared 24491200.0% in 2024.
Over 5 years, Total Debt stood at $1.5 million in 2020, then plunged by 93.58% to $93489.0 in 2021, then surged by 34.23% to $125491.0 in 2022, then sank by 99.99% to $9.0 in 2023, then soared by 4022355.56% to $362021.0 in 2024.
According to Business Quant data, Total Debt over the past three periods registered $362021.0, $2.2 million, and $1.1 million for Q4 2024, Q3 2024, and Q2 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-	-5.81 Bn
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn	16.59 Bn
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn	9.05 Bn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	31.47 Bn
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn	-
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn	13.35 Bn
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn	-
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn	3.92 Bn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	760.00 Mn
10	cbdMD	5.41 Mn	3.29 Mn	3.04 Mn	-

Download Data